Astrana Health (NASDAQ:ASTH) Shares Gap Down – Here’s What Happened

Astrana Health, Inc. (NASDAQ:ASTH) shares gapped down before the market opened on Tuesday . The stock had previously closed at $42.40, but opened at $41.00. Astrana Health shares last traded at $41.00, with a volume of 197 shares trading hands.

Analyst Ratings Changes

A number of analysts have recently commented on the stock. Stifel Nicolaus lifted their price target on shares of Astrana Health from $48.00 to $60.00 and gave the stock a “buy” rating in a research note on Thursday, August 1st. BTIG Research boosted their target price on shares of Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research note on Thursday, October 3rd. TD Cowen initiated coverage on Astrana Health in a research note on Monday, October 14th. They issued a “buy” rating and a $66.00 price target on the stock. Truist Financial upped their price objective on Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a research report on Friday, August 9th. Finally, KeyCorp assumed coverage on Astrana Health in a research report on Friday, October 11th. They issued a “sector weight” rating on the stock. One equities research analyst has rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $65.17.

Astrana Health Stock Up 0.9 %

The company has a 50-day moving average of $53.65 and a two-hundred day moving average of $47.98. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91. The company has a market capitalization of $2.41 billion, a PE ratio of 32.97, a P/E/G ratio of 1.97 and a beta of 1.24.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.33. The firm had revenue of $478.71 million for the quarter, compared to analysts’ expectations of $462.01 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. During the same period in the previous year, the firm earned $0.47 EPS. Sell-side analysts anticipate that Astrana Health, Inc. will post 1.17 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Astrana Health

A number of hedge funds have recently modified their holdings of the company. GAMMA Investing LLC purchased a new stake in Astrana Health in the 3rd quarter worth $34,000. Nisa Investment Advisors LLC purchased a new stake in shares of Astrana Health during the third quarter worth about $35,000. KBC Group NV purchased a new stake in shares of Astrana Health during the third quarter worth about $70,000. Quarry LP bought a new stake in Astrana Health during the 3rd quarter valued at approximately $77,000. Finally, Quest Partners LLC purchased a new position in Astrana Health in the 3rd quarter worth approximately $133,000. 52.77% of the stock is currently owned by institutional investors.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.